TuisGUD • TSE
add
Knight Therapeutics Inc
Vorige sluiting
$6,43
Dagwisseling
$6,32 - $6,45
Jaarwisseling
$5,09 - $6,55
Markkapitalisasie
631,81 m CAD
Gemiddelde volume
69,65 k
P/V-verhouding
5 711,71
Dividend-opbrengs
-
Primêre beurs
TSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CAD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 107,36 m | 12,33% |
Bedryfskoste | 48,50 m | 13,20% |
Netto inkomste | -12,62 m | -549,95% |
Netto winsgrens | -11,76 | -479,31% |
Wins per aandeel | -0,09 | -411,60% |
EBITDA | 8,47 m | -52,05% |
Effektiewe belastingkoers | 19,14% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CAD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 116,42 m | -26,07% |
Totale bates | 1,04 mjd | 9,79% |
Totale aanspreeklikheid | 274,89 m | 50,57% |
Totale ekwiteit | 763,06 m | — |
Uitstaande aandele | 99,65 m | — |
Prys om te bespreek | 0,84 | — |
Opbrengs op bates | -0,90% | — |
Opbrengs op kapitaal | -1,07% | — |
Kontantvloei
Netto kontantverandering
| (CAD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -12,62 m | -549,95% |
Kontant van bedrywe | 20,25 m | 1 964,83% |
Kontant van beleggings | -101,29 m | -961,86% |
Kontant van finansiering | 50,81 m | 547,21% |
Netto kontantverandering | -34,34 m | -1 593,24% |
Beskikbare kontantvloei | 19,41 m | 216,15% |
Meer oor
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Gestig
2014
Hoofkwartier
Webwerf
Werknemers
745
